Skip to content
Syntara logo

Syntara Alternatives & Competitors

11 companies similar to Syntara — Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases li...

Companies similar to Syntara

Nordic Bioscience logo — alternative to Syntara

Nordic Bioscience

Improving preclinical and clinical trial success rates with world-leading biomarkers & spe...

Salmedix logo — alternative to Syntara

Salmedix

Pioneering advanced treatments for blood cancers, delivering innovative Phase II clinical...

Third Harmonic Bio logo — alternative to Syntara

Third Harmonic Bio

Advancing the next wave of medicine for inflammatory diseases

Chemomab Therapeutics logo — alternative to Syntara

Chemomab Therapeutics

Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation...

Rival Readout

Competing with Syntara? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Galmed Pharmaceuticals Ltd. logo — alternative to Syntara

Galmed Pharmaceuticals Ltd.

A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflamm...

GEn1E Lifesciences Inc. logo — alternative to Syntara

GEn1E Lifesciences Inc.

Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Di...

Redx Pharma logo — alternative to Syntara

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

Relmada Therapeutics, Inc logo — alternative to Syntara

Relmada Therapeutics, Inc

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the tre...

BeBetter Med logo — alternative to Syntara

BeBetter Med

Clinical-stage drug discovery and development of advanced novel medicines for cancer and o...

Cleave Therapeutics, Inc. logo — alternative to Syntara

Cleave Therapeutics, Inc.

VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases

Kinarus Therapeutics logo — alternative to Syntara

Kinarus Therapeutics

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...

About Syntara

Syntara (ASX:SNT) is a clinical stage drug developer focusing on diseases associated with fibrosis and inflammation. The company, founded in 1998, specializes in targeting extracellular matrix dysfunction using its expertise in amine oxidase chemistry. Its lead candidate SNT-5505 has received FDA Orphan Drug Designatio...

Business keywords

Clinical Stage Drug Development, Extracellular Matrix Dysfunction, Amine Oxidase Chemistry, Drug Candidates, Fibrotic Diseases, Inflammatory Diseases, Blood Cancers, Respiratory Products, Royalties, Neuroinflammation, Chronic Fibrosis, Haematological Malignancies, Myelofibrosis, Myelodysplastic Syndrome, Scar Management

Frequently Asked Questions

Companies similar to Syntara include Nordic Bioscience, Salmedix, Third Harmonic Bio, Chemomab Therapeutics, Galmed Pharmaceuticals Ltd.. They work in Biotechnology and Health Care and share Syntara's focus on inflammatory diseases, blood cancers and fibrotic diseases.
Bounce Watch lists 11 companies that share Syntara's industries and are closest to it in business tags, services, target customers, business model and size.
Syntara (ASX:SNT) is a clinical stage drug developer focusing on diseases associated with fibrosis and inflammation. The company, founded in 1998, specializes in targeting extracellular matrix dysfunction using its expertise in amine oxidase chemistry. Its lead candidate SNT-5505 has received FDA Orphan Drug Designatio...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Syntara: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Syntara on 6 Dec 2024. The 11 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout